News
NSRX
2.880
-9.15%
-0.290
Nasus Pharma Advances Intranasal Ondansetron After Positive Preclinical Data
TipRanks · 3d ago
Nasus Pharma Announces NS003 Trial Demonstrates Preclinical Pharmacokinetic Profile Comparable To IV
Benzinga · 4d ago
Weekly Report: what happened at NSRX last week (0601-0605)?
Weekly Report · 5d ago
Weekly Report: what happened at NSRX last week (0525-0529)?
Weekly Report · 06/01 09:22
Weekly Report: what happened at NSRX last week (0518-0522)?
Weekly Report · 05/25 09:23
Weekly Report: what happened at NSRX last week (0511-0515)?
Weekly Report · 05/18 09:23
Weekly Report: what happened at NSRX last week (0504-0508)?
Weekly Report · 05/11 09:22
Weekly Report: what happened at NSRX last week (0427-0501)?
Weekly Report · 05/04 09:21
Nasus Pharma to Participate in Upcoming Investor Conferences
Barchart · 05/01 08:14
Weekly Report: what happened at NSRX last week (0420-0424)?
Weekly Report · 04/27 09:22
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 04/22 17:05
Weekly Report: what happened at NSRX last week (0413-0417)?
Weekly Report · 04/20 09:21
Weekly Report: what happened at NSRX last week (0406-0410)?
Weekly Report · 04/13 09:22
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 04/10 21:13
Weekly Report: what happened at NSRX last week (0330-0403)?
Weekly Report · 04/06 09:22
Nasus Pharma’s CEO Makes Bold Move With Fresh Insider Buy
TipRanks · 04/02 02:07
Weekly Report: what happened at NSRX last week (0323-0327)?
Weekly Report · 03/30 09:22
Nasus Pharma Price Target Cut to $18.00/Share From $19.00 by Citizens
Dow Jones · 03/26 13:16
Nasus Pharma Is Maintained at Market Outperform by Citizens
Dow Jones · 03/26 13:16
Citizens Maintains Market Outperform on Nasus Pharma, Lowers Price Target to $18
Benzinga · 03/26 13:05
More
Webull provides a variety of real-time NSRX stock news. You can receive the latest news about Nasus Pharma Ltd. through multiple platforms. This information may help you make smarter investment decisions.
About NSRX
Nasus Pharma Ltd is an Israel-based pharmaceutical company. The Company conducts ins business activities as a pharmaceutical preparation and intranasal powder-based drug delivery systems manufacturer. Its microsphere technology enables rapid, non-invasive administration of medications for conditions such as anaphylaxis and opioid overdose among others. Nasus Pharma Ltd's formulations are designed for relatively fast absorption, ease of use, and effectiveness in critical situations (such as emergency use). The Company's products predominantly aim to improve access to life-saving treatments by allowing easy administration by caregivers or non-professionals, as well as medical doctors and emergency nurses.